Definitive Radiation Therapy for Inoperable Breast Cancer

The purpose of this study is to find out if adding radiation therapy to routine medications for breast cancer helps in reducing and preventing the cancer from getting worse. Patients with a locally advanced breast cancer who cannot, or do not want to, undergo surgery are eligible to participate. Participation in this study does not prevent you from undergoing surgery in the future.

Trial Details

NCT ID
NCT07122713
Phase
NA
Sponsor
Alexander Stessin
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Whole breast radiation with simultaneous integrated boost (WB-SIB) to primary breast tumor
  • Whole breast radiation with simultaneous integrated boost (WB-SIB) to primary breast tumor and ipsilateral axillary lymph nodes
Locations (sample)
  • Stony Brook, New York, United States|40.92565,-73.14094

Key Eligibility Criteria

  • Biopsy proven invasive carcinoma of the breast, either lobular, ductal and/or no special type
  • T1-T4, N0-2, M0-1 invasive breast carcinoma by radiological or clinical criteria
  • Cancer is deemed unresectable, or the patient is a poor surgical candidate as determined following evaluation by a surgeon, or patient declines sur…
  • Life expectancy \> 6 months

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →